Physician profile
Michael J Prayson
NPI 1538125661
$7,688.32
in general payments reported to CMS, 2019-2025
10 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $113 · 2021: $101 · 2022: $5,887 · 2023: $742 · 2024: $253 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $4,180.00 | 2022 | |
| Smith+Nephew, INC. | $2,438.29 | 2019-2025 | Evos, Trigen Intertan, Maverick |
| Si-Bone, INC. | $297.57 | 2019-2024 | |
| Depuy Synthes Sales INC. | $206.63 | 2019-2023 | Fibergraft Aeridyan Matrix |
| Stryker Corporation | $162.91 | 2022-2023 | T2 Alpha |
| Nuvasive Specialized Orthopedics, INC. | $126.87 | 2019 | |
| Zimmer Biomet Holdings, INC. | $113.86 | 2023 | |
| Medartis INC. | $90.97 | 2022 | |
| Acumed LLC | $57.28 | 2024 | Acumed |
| Orthofix Medical, INC. | $13.94 | 2023 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Prayson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.